Author:
Benetti Ayca Altay,Benetti Camillo
Publisher
Springer Nature Singapore
Reference39 articles.
1. Yu, L. X., et al. (2014). Understanding pharmaceutical quality by design. The AAPS Journal, 16(4), 771–783. https://doi.org/10.1208/s12248-014-9598-3
2. Djuris, J., Ibric, S., & Djuric, Z. (2013). Quality-by-design in pharmaceutical development. Woodhead Publishing Limited.
3. Beg, S., Rahman, M., & Kohli, K. (2019). Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products. Drug Discovery Today, 24(3), 717–725. https://doi.org/10.1016/j.drudis.2018.12.002
4. International Council for Harmonisation. (2009). EMEA/CHMP, 2009, ICH Topic Q 8 (R2) pharmaceutical development, step 5: note for guidance on pharmaceutical development (Vol. 8). European Medicines Agency.
5. International Council for Harmonisation. (2015). ICH guideline Q9 on quality risk management (Vol. 44 (1), pp. 1–20). European Medicines Agency.